KPRX logo

Kiora Pharmaceuticals (KPRX) Accounts Payable

Annual Accounts Payable

$206.30 K
-$802.00 K-79.54%

December 1, 2023


Summary


Performance

KPRX Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKPRXbalance sheetmetrics:

Quarterly Accounts Payable

$660.40 K
+$391.80 K+145.87%

September 1, 2024


Summary


Performance

KPRX Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherKPRXbalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

KPRX Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-79.5%+426.6%
3 y3 years-52.5%+403.0%
5 y5 years+223.9%+403.0%

KPRX Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-79.5%+28.5%-34.5%+426.6%
5 y5-year-79.5%+28.5%-34.5%+1009.9%
alltimeall time-85.4%+1405.8%-53.2%+8053.1%

Kiora Pharmaceuticals Accounts Payable History

DateAnnualQuarterly
Sep 2024
-
$660.40 K(+145.9%)
Jun 2024
-
$268.60 K(-16.9%)
Mar 2024
-
$323.10 K(+56.6%)
Dec 2023
$206.30 K(-79.5%)
$206.30 K(+64.5%)
Sep 2023
-
$125.40 K(-4.5%)
Jun 2023
-
$131.30 K(-77.7%)
Mar 2023
-
$587.50 K(-41.7%)
Dec 2022
$1.01 M(+527.8%)
$1.01 M(+34.6%)
Sep 2022
-
$749.20 K(-4.7%)
Jun 2022
-
$785.80 K(+159.9%)
Mar 2022
-
$302.30 K(+88.2%)
Dec 2021
$160.60 K(-63.1%)
$160.60 K(-62.2%)
Sep 2021
-
$424.90 K(+45.4%)
Jun 2021
-
$292.30 K(-36.1%)
Mar 2021
-
$457.30 K(+5.2%)
Dec 2020
$434.80 K(+106.8%)
$434.80 K(+630.8%)
Sep 2020
-
$59.50 K(-36.9%)
Jun 2020
-
$94.30 K(-40.3%)
Mar 2020
-
$158.00 K(-24.9%)
Dec 2019
$210.30 K
$210.30 K(-80.3%)
Sep 2019
-
$1.07 M(+1005.2%)
Jun 2019
-
$96.60 K(-60.4%)
DateAnnualQuarterly
Mar 2019
-
$244.20 K(+283.4%)
Dec 2018
$63.70 K(-91.0%)
$63.70 K(-80.4%)
Sep 2018
-
$324.20 K(-8.9%)
Jun 2018
-
$356.00 K(+60.4%)
Mar 2018
-
$221.90 K(-68.6%)
Dec 2017
$706.10 K(-50.0%)
$706.10 K(+7.2%)
Sep 2017
-
$658.60 K(-32.2%)
Jun 2017
-
$970.90 K(-25.9%)
Mar 2017
-
$1.31 M(-7.2%)
Dec 2016
$1.41 M(+238.1%)
$1.41 M(+0.6%)
Sep 2016
-
$1.40 M(+14.1%)
Jun 2016
-
$1.23 M(+41.5%)
Mar 2016
-
$869.30 K(+108.1%)
Dec 2015
$417.70 K(-26.2%)
$417.70 K(+164.2%)
Sep 2015
-
$158.10 K(-53.2%)
Jun 2015
-
$337.60 K(+18.0%)
Mar 2015
-
$286.20 K(-49.4%)
Dec 2014
$565.90 K(+4030.7%)
$565.90 K(+105.3%)
Sep 2014
-
$275.70 K(+20.1%)
Jun 2014
-
$229.60 K(+2734.6%)
Mar 2014
-
$8100.00(-40.9%)
Dec 2013
$13.70 K(-87.5%)
$13.70 K
Dec 2012
$109.70 K
-

FAQ

  • What is Kiora Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Kiora Pharmaceuticals?
  • What is Kiora Pharmaceuticals annual accounts payable year-on-year change?
  • What is Kiora Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Kiora Pharmaceuticals?
  • What is Kiora Pharmaceuticals quarterly accounts payable year-on-year change?

What is Kiora Pharmaceuticals annual accounts payable?

The current annual accounts payable of KPRX is $206.30 K

What is the all time high annual accounts payable for Kiora Pharmaceuticals?

Kiora Pharmaceuticals all-time high annual accounts payable is $1.41 M

What is Kiora Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, KPRX annual accounts payable has changed by -$802.00 K (-79.54%)

What is Kiora Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of KPRX is $660.40 K

What is the all time high quarterly accounts payable for Kiora Pharmaceuticals?

Kiora Pharmaceuticals all-time high quarterly accounts payable is $1.41 M

What is Kiora Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, KPRX quarterly accounts payable has changed by +$535.00 K (+426.63%)